This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shiao, Y.-H. Articles by Correa, P. Search for Related Content PubMed PubMed Citation Articles by Shiao, Y.-H. Articles by Correa, P.

Racial Disparity in the Association of p53 Gene Alterations with Breast Cancer Survival¹

Department of Pathology, Louisiana State University Medical Center, New Orleans, Louisiana 70112

A significant black/white difference in breast cancer prognosis has been observed in the United States. Alterations of p53 tumor suppressor gene in breast cancer have been associated with poor prognosis. This study was designed to test the hypothesis that p53 gene alterations are related to the difference in prognosis between black and white breast cancer patients. Formalin-fixed paraffin-embedded breast tissue blocks were available from 45 black and 47 white patients for PCR-single strand conformation polymorphism analysis and DNA sequencing. The types of p53 gene alterations were compared between blacks and whites. Associations between p53 gene alterations and survival were also evaluated. Three missense, 2 nonsense, 1 microdeletion, 1 intron, and 4 silent mutations were detected in blacks, while 7 missense, 1 microdeletion, 1 silent mutation, and 3 polymorphisms were observed in whites. Among the point mutations, G:C to A:T transitions at non-CpG sites were found in 80.0% of blacks (8 of 10) and 62.5% of whites (5 of 8). Significantly poorer survival associated with p53 gene alterations was observed for blacks (P = 0.012), but not for whites. Black patients with p53 alterations had a significant 4–5-fold excess risk of death from breast cancer than those without p53 alterations. Adjustment for stage, age, tumor histopathology, receptor status, and adjuvant treatment did not change the excess risk. The findings suggest that the types of p53 gene alterations may contribute to the racial difference in breast cancer survival.

¹ This work was supported in part by the Cancer Association of Greater New Orleans, Louisiana State University Medical Center Stanley S. Scott Cancer Center, and United States Public Health Service Contract NO1-CN-45175.

² To whom requests for reprints should be addressed, at Department of Pathology, Louisiana State University Medical Center, 1901 Perdido Street, New Orleans, LA 70112.

Received 9/ 2/94. Accepted 2/ 1/95.

This article has been cited by other articles:

				B. N. Polite, C. Cirrincione, G. F. Fleming, D. A. Berry, A. Seidman, H. Muss, L. Norton, C. Shapiro, K. Bakri, K. Marcom, et al. Racial Differences in Clinical Outcomes From Metastatic Breast Cancer: A Pooled Analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B J. Clin. Oncol., June 1, 2008; 26(16): 2659 - 2665. [Abstract] [Full Text] [PDF]

				L. A. Newman Breast Cancer in African-American Women Oncologist, January 1, 2005; 10(1): 1 - 14. [Abstract] [Full Text] [PDF]

				V. H. Murthy, H. M. Krumholz, and C. P. Gross Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities JAMA, June 9, 2004; 291(22): 2720 - 2726. [Abstract] [Full Text] [PDF]

				L. X. Clegg, F. P. Li, B. F. Hankey, K. Chu, and B. K. Edwards Cancer Survival Among US Whites and Minorities: A SEER (Surveillance, Epidemiology, and End Results) Program Population-Based Study Arch Intern Med, September 23, 2002; 162(17): 1985 - 1993. [Abstract] [Full Text] [PDF]

				M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J. Med. Genet., April 1, 2002; 39(4): 225 - 242. [Abstract] [Full Text] [PDF]

				B. Powell, R. Soong, B. Iacopetta, R. Seshadri, and D. R. Smith Prognostic Significance of Mutations to Different Structural and Functional Regions of the p53 Gene in Breast Cancer Clin. Cancer Res., February 1, 2000; 6(2): 443 - 451. [Abstract] [Full Text]

				P. Robbins p53 and Breast Cancer International Journal of Surgical Pathology, October 1, 1996; 4(2): 93 - 110. [Abstract] [PDF]